Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.035 BRL
−23.11 M BRL
1.01 B BRL
190.28 M
About ESPACOLASER ON NM
Sector
Industry
Headquarters
São Paulo
Website
Founded
2004
ISIN
BRESPAACNOR7
FIGI
BBG00YVGP757
MPM Corpóreos SA engages in the provision of aesthetic services. It operates a chain of hair removal clinics. The company was founded by Tito Virgílio Augusto Veiga Pinto, Paulo José Iász de Morais, and Ygor Alessandro de Moura in 2004 and is headquartered in Sao Paulo, Brazil.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ESPA3 is 0.970 BRL — it has increased by 2.11% in the past 24 hours. Watch ESPACOLASER ON NM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange ESPACOLASER ON NM stocks are traded under the ticker ESPA3.
ESPA3 stock has risen by 3.19% compared to the previous week, the month change is a −3.00% fall, over the last year ESPACOLASER ON NM has showed a −16.38% decrease.
We've gathered analysts' opinions on ESPACOLASER ON NM future price: according to them, ESPA3 price has a max estimate of 1.60 BRL and a min estimate of 1.10 BRL. Watch ESPA3 chart and read a more detailed ESPACOLASER ON NM stock forecast: see what analysts think of ESPACOLASER ON NM and suggest that you do with its stocks.
ESPA3 reached its all-time high on Feb 2, 2021 with the price of 22.454 BRL, and its all-time low was 0.860 BRL and was reached on Apr 17, 2024. View more price dynamics on ESPA3 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ESPA3 stock is 3.16% volatile and has beta coefficient of 1.15. Track ESPACOLASER ON NM stock price on the chart and check out the list of the most volatile stocks — is ESPACOLASER ON NM there?
Yes, you can track ESPACOLASER ON NM financials in yearly and quarterly reports right on TradingView.
ESPACOLASER ON NM is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ESPA3 earnings for the last quarter are 0.01 BRL per share, whereas the estimation was 0.04 BRL resulting in a −75.00% surprise. The estimated earnings for the next quarter are 0.02 BRL per share. See more details about ESPACOLASER ON NM earnings.
ESPACOLASER ON NM revenue for the last quarter amounts to 248.95 M BRL, despite the estimated figure of 245.85 M BRL. In the next quarter, revenue is expected to reach 239.49 M BRL.
ESPA3 net income for the last quarter is 1.67 M BRL, while the quarter before that showed 6.07 M BRL of net income which accounts for −72.48% change. Track more ESPACOLASER ON NM financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ESPACOLASER ON NM EBITDA is 245.35 M BRL, and current EBITDA margin is 20.93%. See more stats in ESPACOLASER ON NM financial statements.
Like other stocks, ESPA3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ESPACOLASER ON NM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ESPACOLASER ON NM technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ESPACOLASER ON NM stock shows the sell signal. See more of ESPACOLASER ON NM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.